Cardiff Lexington CORP S-1 registration statements

Cardiff Lexington Corporation has entered into a common stock purchase agreement with Leonite Fund I, LP to sell up to $75 million in common stock.

Cardiff Lexington Corporation filed an S-1/A, detailing a proposed 1.2 million share common stock offering contingent on a Nasdaq uplisting, alongside recent financial losses and ongoing liquidity concerns.

Cardiff Lexington Corporation filed an Amendment No. 2 to its S-1 Registration Statement, detailing the terms for a public offering of common stock and representative warrants.

Cardiff Lexington Corporation is offering 1.5 million shares of common stock at an assumed price of $4.00 per share, contingent on its uplisting to The Nasdaq Capital Market, despite ongoing financial challenges including recurring net losses and a going concern doubt.

Cardiff Lexington Corporation files an S-1 registration statement for a common stock offering, contingent on a Nasdaq Capital Market uplisting, amidst recurring operating losses and an extended accounts receivable cycle.

Cardiff Lexington Corporation files Amendment No. 6 to its Form S-1/A registration statement, primarily to include updated exhibits related to its proposed offering of common stock and related securities.

Cardiff Lexington Corporation files an amendment to its Form S-1/A registration statement, aiming to offer 1,600,000 shares of common stock and uplist to the Nasdaq Capital Market under the symbol CDIX.

Cardiff Lexington Corporation files an amendment to its Form S-1 registration statement, addressing comments from the SEC and updating financial information.

Cardiff Lexington Corporation files an amended registration statement for a proposed offering of 1,600,000 shares of common stock, contingent upon uplisting to NYSE American or Nasdaq.

Cardiff Lexington Corporation files an amendment to its Form S-1/A registration statement, aiming to offer 1,600,000 shares of common stock and uplist to NYSE American under the symbol CDIX.